Characterization of CoCas9 nuclease from


Journal

RNA biology
ISSN: 1555-8584
Titre abrégé: RNA Biol
Pays: United States
ID NLM: 101235328

Informations de publication

Date de publication:
01 2023
Historique:
medline: 4 10 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

Cas9 nucleases are widely used for genome editing and engineering. Cas9 enzymes encoded by CRISPR-Cas defence systems of various prokaryotic organisms possess different properties such as target site preferences, size, and DNA cleavage efficiency. Here, we biochemically characterized CoCas9 from

Identifiants

pubmed: 37743659
doi: 10.1080/15476286.2023.2256578
pmc: PMC10521337
doi:

Substances chimiques

CRISPR-Associated Protein 9 EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

750-759

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Mol Ther. 2022 Jan 5;30(1):256-267
pubmed: 34174445
Nature. 2014 Sep 25;513(7519):569-73
pubmed: 25079318
J Infect. 2007 Feb;54(2):e107-9
pubmed: 16882454
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86
pubmed: 22949671
RNA Biol. 2020 Oct;17(10):1472-1479
pubmed: 32564655
Nature. 2018 Apr 5;556(7699):57-63
pubmed: 29512652
Nature. 2019 Dec;576(7785):149-157
pubmed: 31634902
Nat Rev Microbiol. 2020 Feb;18(2):67-83
pubmed: 31857715
Science. 2008 Aug 15;321(5891):960-4
pubmed: 18703739
J Mol Evol. 2005 Feb;60(2):174-82
pubmed: 15791728
Nucleic Acids Res. 2011 Nov;39(21):9275-82
pubmed: 21813460
Nat Methods. 2013 Nov;10(11):1116-21
pubmed: 24076762
J Mol Biol. 2017 Jan 20;429(2):177-191
pubmed: 27916599
Nat Commun. 2020 Nov 2;11(1):5512
pubmed: 33139742
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
J Clin Microbiol. 2007 Feb;45(2):645-7
pubmed: 17135428
Nature. 2015 Apr 9;520(7546):186-91
pubmed: 25830891
Nat Commun. 2022 Mar 17;13(1):1425
pubmed: 35301321
Anaerobe. 2012 Feb;18(1):157-61
pubmed: 22252100
Microbiology (Reading). 2005 Aug;151(Pt 8):2551-2561
pubmed: 16079334
Elife. 2022 Aug 12;11:
pubmed: 35959889
Mol Cell. 2016 Apr 7;62(1):137-47
pubmed: 27041224
Nat Biotechnol. 2023 Jan;41(1):96-107
pubmed: 36076084
Front Microbiol. 2019 Oct 25;10:2471
pubmed: 31708910
Science. 2020 Apr 17;368(6488):290-296
pubmed: 32217751
Nat Commun. 2021 Jan 22;12(1):555
pubmed: 33483498
Science. 2008 Dec 19;322(5909):1843-5
pubmed: 19095942
RNA Biol. 2013 May;10(5):817-27
pubmed: 23492433
PLoS Biol. 2020 Mar 30;18(3):e3000686
pubmed: 32226015
Nature. 2015 Jul 23;523(7561):481-5
pubmed: 26098369
Science. 2007 Mar 23;315(5819):1709-12
pubmed: 17379808
Nat Protoc. 2021 Feb;16(2):1089-1128
pubmed: 33462442
PLoS One. 2016 Jan 22;11(1):e0147114
pubmed: 26800339
Cell. 2014 Feb 27;156(5):935-49
pubmed: 24529477
Nat Biomed Eng. 2022 Nov;6(11):1272-1283
pubmed: 35902773
Mol Cell. 2019 Feb 21;73(4):714-726.e4
pubmed: 30581144
Mol Cell. 2016 Mar 17;61(6):797-808
pubmed: 26949040
Nature. 2010 Nov 4;468(7320):67-71
pubmed: 21048762
Mol Biol Evol. 2021 Jun 25;38(7):3022-3027
pubmed: 33892491
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
Nat Commun. 2020 May 18;11(1):2474
pubmed: 32424114
Nat Commun. 2017 Feb 21;8:14500
pubmed: 28220790
Nature. 2011 Mar 31;471(7340):602-7
pubmed: 21455174

Auteurs

A Vasileva (A)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
Complex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.

P Selkova (P)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
Complex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.

A Arseniev (A)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
Complex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.

M Abramova (M)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.

N Shcheglova (N)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.

O Musharova (O)

Complex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.

I Mizgirev (I)

Laboratory of Carcinogenesis and Aging, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia.

T Artamonova (T)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.

M Khodorkovskii (M)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.

K Severinov (K)

Complex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.
Waksman Institute, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.

I Fedorova (I)

Center of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH